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The present study was designed to investigate the cardioprotective effects ofMalaysian Tualang honey against isoproterenol- (ISO-)
induced myocardial infarction (MI) in rats by investigating changes in the levels of cardiac marker enzymes, cardiac troponin I
(cTnI), triglycerides (TG), total cholesterol (TC), lipid peroxidation (LPO) products, and antioxidant defense system combined
with histopathological examination. Male albinoWistar rats (n = 40) were pretreated orally with Tualang honey (3 g/kg/day) for 45
days. Subcutaneous injection of ISO (85mg/kg in saline) for two consecutive days caused a significant increase in serum cardiac
marker enzymes (creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), and aspartate transaminase (AST)), cTnI, serum
TC, and TG levels. In addition, ISO-induced myocardial injury was confirmed by a significant increase in heart lipid peroxidation
(LPO) products (TBARS) and a significant decrease in antioxidant enzymes (SOD, GPx, GRx, and GST). Pretreatment of ischemic
rats with Tualang honey conferred significant protective effects on all of the investigated biochemical parameters. The biochemical
findings were further confirmed by histopathological examination in both Tualang-honey-pretreated and ISO-treated hearts. The
present study demonstrates that Tualang honey confers cardioprotective effects on ISO-induced oxidative stress by contributing to
endogenous antioxidant enzyme activity via inhibition of lipid peroxidation.
1. Introduction
Oxidative stress due to excess production of reactive oxygen
species (ROS), along with free radicals, has been implicated
in a large number of diseases, including cardiovascular
diseases (CVDs), liver diseases, and neurodegenerative dis-
eases including Alzheimer’s and Parkinson’s disease [1, 2].
Myocardial infarction (MI) is a presentation of ischemic
heart disease (IHD) that is defined as an acute condition
of necrosis of the myocardium resulting from an imbalance
between myocardial metabolic demands and the coronary
supply of oxygen and nutrients. IHD is one of the most lethal
manifestations of cardiovascular disease [3–5]. According to
the World Health Organization, MI is the major cause of
death in the developed world and a cause of major pathology
worldwide. By 2020, MI is predicted to be the major cause of
death in the world [6, 7].
Oxidative deterioration of membrane polyunsaturated
fatty acids (PUFAs) within the myocardium has been linked
to increased levels of lipid peroxides such as thiobarbituric
acid reactive substances (TBARS) and lipid hydroperoxides
(LOOH).These changes occur during the initial stages of MI
and increase the tissue’s susceptibility to oxidative damage.
This is followed by hyperglycemia, hyperlipidemia, peroxi-
dation of membrane phospholipids, and loss of membrane
integrity [4, 8].
Isoproterenol (ISO) is a synthetic catecholamine and 𝛽-
adrenergic agonist. When administered in large doses, it can
cause severe stress in the myocardium that leads to infarct-
like necrosis of the heart muscle [9]. It has been reported
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that ISO-induced cardiac damage is characterized by hypoxia
due to myocardial hyperactivity, coronary hypotension, and
excessive generation of highly cytotoxic free radicals as a
result of auto-oxidation of catecholamines [10].The oxidation
of catecholamines forms quinoid compounds that stimulate
the production of superoxide anions and subsequently hydro-
gen peroxide. In the presence of iron, hydrogen peroxide
becomes a highly reactive hydroxyl radical that causes oxida-
tive damage to proteins, lipids, and DNA, thereby impact-
ing the size of the infarcted myocardium [11]. Myocardial
necrosis is associated with cardiac dysfunction, increased
lipid peroxidation, and altered activities of cardiac enzymes
and the antioxidant system [12, 13]. The pathophysiological
and morphological aberrations produced in the heart of the
myocardial necrotic ratmodel are comparable with those that
occur in human MI [10].
There is an increase in global demand for safe and effec-
tive natural products that confer free radical scavenging activ-
ities and that offer protection against oxidative stress induced
cardiovascular diseases including MI [13]. The dynamic
relationship between ROS and antioxidants results from the
endogenous antioxidant defense system composed of free
radical antioxidant enzymes, such as superoxide dismutase
(SOD), catalase, glutathione peroxidase (GPx), glutathione
reductase (GRx), and glutathione-S-transferase (GST), which
may be lowered due to enhanced lipid peroxidation [8].
In recent years, the prevention of CVD has been linked to
the consumption of fresh food items and plants rich in natural
antioxidants because of their superior efficacy and safety
compared to synthetic products [14]. Honey, a natural liquid
produced by honey bees, has received considerable attention
recently because it contains at least 181 different substances
[15] that are believed to have a therapeutic role in CVD. Its
therapeutic value has been partly attributed to its antioxidant
properties [16].The antioxidant constituents of honey include
phenolics, flavonoids, ascorbic acid, proteins [17], certain
enzymes (glucose oxidase, catalase) [18], 𝛼-tocopherol, and
beta-carotene, a precursor of vitamin A that may reduce the
risk of some forms of fatal diseases such as cancer, CVD, and
stroke [16].
Tualang honey (TH) is a wild multifloral honey produced
by Apis dorsata of Asian origin, which form their hives high
in tall trees locally known as tualang trees [19]. Previous
in vitro studies on the antioxidant properties of Malaysian
honeys revealed that TH had the highest content of phenolics
and flavonoids, as well as the best free radical scavenging
properties when compared to otherMalaysian honey samples
[17, 20]. In addition, the presence of a number of phenolic
acids, including gallic, syringic, benzoic, trans-cinnamic, p-
coumaric acids, and flavonoid compounds such as catechin
and kaempferol, has been identified through high perfor-
mance liquid chromatography (HPLC) analysis [19], further
confirming TH’s scientific importance for human health and
medicine. While some studies have reported a beneficial
role for catechins and kaemferols in cardiovascular function,
the cellular mechanisms underlying their biological actions
remain unknown [16, 21]. Therefore, the present study was
designed to investigate the cardioprotective effects of TH in
rats and to identify the possible mechanisms underlying its
therapeutic efficacy by studying the alterations in cardiac
marker enzymes, troponin I, lipid peroxides, and the antiox-
idant defense system, in conjunction with histopathological
examination.
2. Materials and Methods
2.1. Experimental Animals. The experiments were conducted
using adult male Wistar albino rats (𝑛 = 40) weighing 160–
180 g. The animals were bred and reared in the institutional
animal house facility maintained at a constant room tem-
perature of 30 ± 3∘C, with humidity ranging between 40%
and 70%. The rats were housed in polypropylene cages with
hard wood-chip bedding and received a natural 12-h day-
night cycle. They were fed a standard pellet diet and water ad
libitum.The experiments compliedwith the local institutional
ethical guidelines.
2.2. Drugs and Chemicals. ISO and 1,1,3,3-tetraethoxy
propane were purchased from Nacalai Tesque, Inc., Kyoto,
Japan. All chemicals and reagents used in this study were of
analytical grade.
2.3. Honey Samples. TH samples were provided by the Fed-
eral Agricultural Marketing Authority (FAMA) of Malaysia.
The dose of honey used in this study was based on previous
studies [22, 23].
2.4. Experimental Induction ofMyocardial Ischemia. Myocar-
dial ischemia was induced by subcutaneous (s.c.) injection of
ISO (85mg/kg dissolved in physiological saline) at an interval
of 24 h for two consecutive days. The ISO dose was based
on a pilot study for ISO dose fixation as well as results from
previous studies [4, 24]. Animals were sacrificed 48 h after the
first ISO dose.
2.5. Experimental Design. Following acclimatization, the
experimental rats were randomly divided into four groups
consisting of 10 rats each.
Group 1 (control). Animals received standard laboratory diet
and drinking water ad libitum and served as a normal control
group.
Group 2 (TH). Animals received TH only (3 g/kg) orally for
45 days. (All animals received standard laboratory diet and
drinking water ad libitum).
Group 3 (ISO). Animals were subcutaneously injected with
ISO (85mg/kg) on the 44th and 45th days (at an interval of
24 h) [24]. (All animals received standard laboratory diet and
drinking water ad libitum, and this group served as a negative
control group).
Group 4 (TH + ISO). Animals were orally treated with TH
(3 g/kg) for a period of 45 days followed by subcutaneous
injection of ISO (85mg/kg) on the 44th and 45th days (at an
interval of 24 h). (All animals received standard laboratory
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Table 1: The effects of TH on BW, absolute, and relative heart weights.
Parameters Treatment
Control TH ISO TH + ISO
Initial BW(g) 169.00 ± 7.75a 170.40 ± 6.89a 171.00 ± 4.85a 169.90 ± 8.11a
Final BW (g) 239.50 ± 8.46a 237.10 ± 8.24a 236.20 ± 7.17a 237.00 ± 4.59a
BW gain (%) 29.30 ± 4.29a 27.50 ± 3.09a 27.50 ± 3.26a 28.28 ± 3.91a
Absolute heart weight (g) 0.99 ± 0.07a 0.97 ± 0.08a 1.22 ± 0.01b 1.11 ± 0.14b
Relative heart weight (g/100 g) 0.42 ± 0.02a 0.41 ± 0.02a 0.52 ± 0.01b 0.48 ± 0.05b
Results were expressed as the mean ± SD, 𝑛 = 10. a,b,cValues in the same row that do not share superscript letters (a, b, and c) differ significantly at 𝑝 < 0.05; %
of body weight (BW) gain = [(final BW − initial BW)/final BW] × 100. TH: Tualang Honey; ISO: isoproterenol.
diet and drinking water ad libitum, and this group served as
a preventive group).
2.6. Serum Preparation. Blood samples (3mL) were collected
in dry test tubes and allowed to coagulate at an ambient tem-
perature for 30min. Serum was separated by centrifugation
at 2000 rpm for 10min.
2.7. Heart Tissue Homogenate Preparation. Immediately fol-
lowing blood collection, the heart samples were separated
from the surrounding tissue and were washed twice with
ice cold phosphate buffer saline (PBS). The samples were
homogenized in phosphate buffer (25mM,pH7.4) to produce
an approximately 10%w/v homogenate.The homogenate was
centrifuged at 1700 rpm for 10min and the supernatant was
collected and stored at −20∘C until subsequent biochemical
analysis. Some of the heart samples were stored in 10%
formalin for histopathological examination.
2.8. Serum Biochemical Parameters. The collected serum was
used for determination of cardiac troponin I (cTnI) using
commercially available enzyme immunoassay kits (JAJ Inter-
national Inc., USA). The cardiac marker enzymes creatine
kinase-MB (CK-MB), aspartate transaminase (AST), and
lactate dehydrogenase (LDH) were estimated using com-
mercially available standard assay kits (Standbio Laboratory,
Boerne, TX, USA). Serum was also used for the estimation
of total cholesterol (TC) and triglycerides (TG) using com-
mercially available standard assay kits (Standbio Laboratory,
Boerne, TX, USA).
2.9. Biochemical Parameters on Heart Tissue
2.9.1. Oxidative Stress Biomarker (LPO). Malondialdehyde
(MDA) levels were assayed for products of lipid peroxidation
(LPO) in heart tissue. MDA, which is referred to as thio-
barbituric acid reactive substance (TBARS), was measured
at 532 nm according to the method described by Ohkawa et
al. [25] and the levels of TBARS were expressed as nmol of
MDA per mg of protein. The total protein in heart tissue
homogenates was estimated by the Lowry method [26].
2.9.2. Antioxidant Enzymes. The heart tissue homogenate
was centrifuged again at 12,000 rpm for 10min at 4∘C using a
high speed cooling centrifuge (Eppendorf centrifuge 5415D,
Germany). The yielded supernatant was used for estimation
of endogenous antiperoxidative enzymes, SOD, GPx, GRx,
and GST using standard assay kits (Abnova Corporation,
Taiwan). SOD activity was expressed as units/mg of pro-
tein, while GPx and GRx activity was expressed as nmol
NADPH oxidized/min/mg of protein and GST activity was
expressed as nmol CDNB (1-chloro-2,4-dinitrobenzene) con-
jugated/min/mg of protein.
2.10. Histopathological Examination. After the rats were sac-
rificed, their hearts were rapidly dissected and immediately
washed with saline, followed by fixation in 10% formalin.
The fixed tissues were embedded in paraffin, and then serial
sections of 5 𝜇m thickness were cut. Each section was stained
with hematoxylin and eosin (H & E).Themicroscopic exam-
ination was carried out using a normal-spectra fluorescent
microscope (Olympus DP72) at 40x. Photomicrographs were
then taken with a digital camera (Olympus, Tokyo, Japan)
attached to the microscope. To avoid any possible bias, the
pathologist performing the histopathological examination
was blinded to the treatment assignment of the different study
groups.
2.11. Statistical Analysis. Data were analyzed using SPSS
(Statistical Packages for Social Science, version 20.0, IBM
Corporation, New York, USA) and Microsoft Excel 2007
(Redmond, Washington, USA). Statistical analyses of the
biochemical data were conducted by using Tukey’s test. The
results are presented as mean values ± standard deviations
(SD). A 𝑝 value of < 0.05 was accepted as statistically
significant.
3. Results
There were no deaths in any of the experimental groups
during the treatment period (45 days). Table 1 shows that
there was no significant difference in body weight (BW)
between the different treatment groups; although ISO alone
treated rats had a slight reduction in BW gain compared
with normal controls, this difference was not statistically
significant. ISO administration significantly (𝑝 < 0.05)
increased absolute and relative heart weights compared to
normal controls. Pretreatment with TH followed by ISO
treatment reduced the absolute and relative heart weights to
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Table 2: The protective effects of TH on serum levels of cardiac marker enzymes in rats.
Parameters Treatment
Control TH ISO TH + ISO
CK-MB (U/L) 94.44 ± 3.05a 90.31 ± 6.15a 242.39 ± 7.30c 158.03 ± 7.59b
AST (U/L) 23.13 ± 2.55a 29.87 ± 1.36b 110.08 ± 4.95d 43.62 ± 3.54c
LDH (U/L) 79.82 ± 3.46a 81.98 ± 3.95a 127.44 ± 3.63c 96.20 ± 5.40b
The results are expressed as the mean ± SD, 𝑛 = 10.
a,b,c,dValues in the same row that do not share superscript letters (a, b, c, and d) differ significantly at 𝑝 < 0.05; TH: Tualang honey; ISO: isoproterenol.
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Figure 1: The cardioprotective effects of TH and cTnI levels in rats,
measured using ELISA method. The bars represent the mean ± SD
(𝑛 = 10); bars with different letters are significantly different at 𝑝 <
0.05.
control levels, although this difference was not statistically
significant.
Rats injected with ISO alone showed a marked (𝑝 <
0.05) elevation in the serum cTnI levels when compared to
normal controls. However, oral pretreatment of TH to ISO-
treated rats for a period of 45 days significantly (𝑝 < 0.05)
decreased serum cTnI levels when compared with ISO and
normal control groups (Figure 1).
The induction ofMI following ISO administration signif-
icantly increased all serum cardiac marker enzyme activities
(CK-MB, AST, and LDH) compared to controls. However,
oral pretreatment with honey ameliorated all ISO-induced
alterations of the diagnosticmarker enzymes to normal levels.
No significant differencewas observed in rats treatedwithTH
alone except for a slight increase in AST activity compared to
the control rats (Table 2).
Rats treated with ISO alone showed a significant increase
in serumTC andTG levels when comparedwith normal con-
trols.However, honey pretreatment reduced these parameters
significantly. In the baseline group, rats treated with honey
alone showed slight reductions in serum TC and TG levels
when compared to control rats, although this difference was
not statistically significant (Figure 2).
ISO significantly increased the levels of MDA compared
to normal controls (Table 3). However, a significant diminu-
tion of ISO-induced MDA elevation was observed in all
honey-pretreated groups. The activities of the antioxidant
enzymes SOD, GPx, GRx, and GST in the heart of rats
that were only treated with ISO were significantly decreased
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Figure 2:The protective effects of TH on serumTC and TG levels in
rats, estimated directly using standard assay kit. The bars represent
the mean ± SD (𝑛 = 10); bars with different letters are significantly
different at 𝑝 < 0.05.
compared to controls. Pretreatment of ISO-induced rats with
honey significantly increased the activities of GPx, GRx, and
GST enzymes compared to rats treated with ISO alone.
Figures 3(a)–3(d) show the effects of TH on the
histopathology of heart tissue in normal and ISO-inducedMI
rats. Normal cardiacmuscle fibers with cellular integrity were
observed in normal untreated rats (Figure 3(a)). Normal rats
treated with honey alone also showed normal cardiac muscle
bundles, with no evidence of infarction or tissue damage
(Figure 3(b)). Histopathological evaluation confirmed induc-
tion of MI by ISO with the area of infarction containing
split cardiac muscle fibers, edematous intramuscular spaces,
and inflammatory infiltrates (Figure 3(c)). Pretreatment with
honey (85mg/kg) for 45 days, however, decreased the degree
of infiltration of inflammatory cells, and the treated rats
showed relatively well-preserved cardiac muscle fiber mor-
phology (Figure 3(d)).
4. Discussion
To our knowledge, our study is the first to demonstrate
that TH has cardioprotective effects. Investigation of the
hearts and their relative organ weights revealed a significant
increase in both absolute and relative weights following ISO
administration, although the bodyweight remained relatively
BioMed Research International 5
Table 3: The protective effects of TH on lipid peroxide (LPO) levels and activities of superoxide dismutase (SOD), glutathione reductase
(GRx), glutathione peroxidase (GPx), and glutathione-S-transferase (GST) in the hearts of normal and treated rats.
Parameters Treatment
Control TH ISO TH + ISO
LPO (nmol TBARS/mg of protein) 9.25 ± 0.68a 9.33 ± 0.96a 22.42 ± 1.09c 16.84 ± 1.06b
SOD (units/mg of protein) 1.46 ± 0.05a 1.49 ± 0.09a 0.16 ± 0.01b 0.19 ± 0.02b
GPx
(nmol NADPH oxidized/min/mg of protein) 2.86 ± 0.06
c 2.83 ± 0.05c 1.07 ± 0.19a 1.86 ± 0.20b
GRx
(nmol NADPH oxidized/min/mg of protein) 83.66 ± 2.73
b 85.33 ± 2.18bc 76.59 ± 5.92a 89.05 ± 5.01c
GST
(nmol CDNB conjugated/min/mg of protein) 2.39 ± 0.21
b 3.58 ± 0.04a 0.85 ± 0.02c 1.89 ± 0.23b
Results are expressed as the mean ± SD, 𝑛 = 10.
a,b,cValues in the same row that do not share superscript letters (a, b, and c) differ significantly at 𝑝 < 0.05; TH: Tualang honey; ISO: isoproterenol.
(a) (b)
(c) (d)
Figure 3: Effect of TH on histopathological changes observed on the ventricular wall of heart muscle. (a) Group 1: photomicrograph of
histopathological examination of stainedmyocardial tissue section fromnormal control rats showing normal cardiacmuscle fibers. (b) Group
2: TH-treated (3 g/kg) heart showing normal cardiac muscle fibers with no pathological changes. (c) Group 3: ISO alone (85mg/kg) treated
heart showing separation of cardiac muscle fibers (blue arrows) and edematous intramuscular spaces (black arrows) with infiltration of
inflammatory cells (green arrows). (d) Group 4: honey + ISO-treated heart, indicating that TH conferred some cardioprotection; markedly
increased areas of normal muscle fibers can be observed. (Magnification: 40x).
unchanged. The increase in heart weight may be attributed
to increased water accumulation in edematous intramuscular
spaces in cardiac tissue and increased protein content [27],
which was also confirmed on histopathological examination.
These results are consistent with a previous report on ISO-
induced myocardial ischemia [13]. It has been proposed that
myocardial function may be reduced by approximately 10%
with a 1% increase inmyocardial water content [28]. Pretreat-
ment with TH, however, slightly decreased the relative heart
weight to near normal, which is indicative of its protective
effect on the myocardium.
It has been reported that ISO-induced cytotoxic free
radical generation and the development of infarct-like lesions
of the subendocardiumwith coronary insufficiency have been
observed in experimental animal studies [10, 13]. Flavonoids
such as catechin and kaempferol, phenolic acids, ascorbic
acid, and proteins are important constitutive antioxidants
that have been detected in TH [17, 19], all of which can work
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synergistically to scavenge and eliminate free radicals [29]. It
is plausible that the presence of these antioxidants may help
to protect against oxidative cardiac injury, thus restricting the
leakage of these enzymes from the myocardium.
cTnI is a low molecular weight protein constituent of the
myofibrillary contractile apparatus of the cardiac muscle. It is
a sensitive and a highly specific diagnostic marker of MI [30,
31]. Elevated cTnI levels can predict the risk of both cardiac
death and subsequent infarction and can serve as a predictor
of myocardial ischemia in patients subjected to a stress test
[8, 32]. In our study, increased cTnI levels were observed in
the serum of ISO-induced rats. Our results are consistent
with a previous study reported by Priscilla and Prince [8].
Pretreatment with honey significantly decreased serum cTnI
levels in ISO-induced cardiotoxic rats.This result may be due
to the protective effect of TH on the myocardium through
preservation of the structural and functional integrity of the
contractile apparatus, thereby preventing cardiac injury and
leakage of troponins from myocardium into the blood circu-
lation. Further investigation of the mechanisms underlying
the cardioprotective effects of TH is warranted.
The myocardium contains ample concentrations of diag-
nostic markers of MI and, when damaged, releases its con-
tents into the extracellular fluid [27]. Once myocardial cells
are damaged or destroyed due to insufficient oxygen supply
or nutrients, the cardiac membrane becomes permeable or
may rupture, resulting in leakage of cytosolic enzymes into
the blood stream with concomitant increases of their serum
concentrations [33]. Consistent with previous studies [13,
31], in the present study, ISO administration to rats caused
marked elevations in all of the serum cardiac marker enzyme
activities. CK-MB activity in the serum is a sensitive and
important diagnostic marker of MI because of its abundance
in myocardial tissue and its virtual absence from most
other tissues [34]. Pretreatment with honey significantly
lowered the ISO-induced elevation of serum levels of the
cardiac marker enzymes, demonstrating that TH maintains
membrane integrity and restricts the leakage of these cardiac
enzymes. No significant changes were observed in cardiac
markers in rats treated solely with TH. Although serum AST
activity was slightly elevated, other diagnostic parameters
strongly supported the ameliorative effect of TH honey on
oxidative stress.
An important factor in CVD is the key role that lipids play
in the pathogenesis of CVD not only via hyperlipidemia and
the development of atherosclerosis but also by modifying the
composition, structure, and stability of cellular membranes
[35]. ISO-induced rats exhibited significant elevation in
serum total cholesterol and triglycerides. These alterations
could be attributed to enhanced biogenesis of lipids by the
cardiac cAMP cascade [36]. Our observations are consistent
with previous reports by Patel et al. [13] and Radhiga et al. [4].
Honey pretreatment restored TC and TG levels in treatment
rats. Alagwu et al. [37] speculated that honey increases bile
cholesterol excretion and lowers plasma cholesterol levels,
though this observation requires further investigation.
ISO auto-oxidation leads to the generation of excessive
amounts of ROS that may primarily target and attack PUFAs
within the cellular membranes and form peroxy radicals that
in turn attack adjacent phospholipids in a chain reaction of
lipid peroxidation [8]. Lipid peroxidation is an important
pathogenic event in MI [38]. MDA is a major lipid perox-
idation end product. Increased MDA concentrations may
result from increased levels of free radicals and/or decreased
activities of the antioxidant defense system [39]. In line
with previous reports [8, 13, 31], in the present study, ISO
administration caused a marked elevation in LPO, which
was expressed as MDA content. Oral pretreatment of rats
with honey led to a significant reduction in myocardial MDA
content. This result can be attributed to the free radical
scavenging activity of TH, by the synergistic scavenging
effects of natural honey maybe due to both enzymatic (e.g.,
catalase, glucose oxidase, and peroxidase) and nonenzymatic
(e.g., phenolic acids, flavonoids, ascorbic acid, carotenoids)
antioxidants involved in cardiovascular defense mechanisms
[40, 41].
Regarding the levels of antiperoxidative enzymes, SOD
activity or glutathione redox system which consists of both
GPx and GRx [42], it is plausible that the observed decreased
activities of SOD, GPx, GRx, and GST in the myocardium
of ISO-treated rats may be due to increased generation
of ROS, such as superoxide and H
2
O
2
. This in turn leads
to inhibition of these enzymes and results in decreased
removal of superoxide radicals, H
2
O
2
radicals, and highly
potent hydroxyl radicals [43]. Honey pretreatment restored
the decreased levels of these enzymes in heart tissue sug-
gesting that TH provides protection from deleterious effects
induced by free radicals in ISO-treated rats. This result could
be due to the direct free radical scavenging potency of
honey [41]. The possible mechanisms through which honey
supplementation restores antioxidant enzyme function may
be due to upregulation of the activity or expression of
Nrf2 [44], a transcription factor that is released from its
repressor (Keap1) under oxidative or xenobiotic stress [45].
The released Nrf2 binds to the antioxidant response element
(ARE) of cytoprotective genes and induces their expression
as well as subsequent induction of free radical scavenging
enzymes to neutralize and eliminate the cytotoxic oxidants
[45, 46].
Histopathological examination of myocardial tissue in
ISO-treated rats revealed coagulative necrosis of myocytes
and separation of cardiac muscle fibers with inflammatory
cell infiltration. In comparison, the nearly normal cardiac
muscle fiber architecture with reduced inflammatory infil-
trates further confirmed the cardioprotective effect of TH.
Similar histopathological findings were observed in ISO-
treated rats for gallic acid [8], which also has high antioxidant
properties. Overall, the results of this study offer scientific
evidence of the importance of TH in cardioprotection against
CVD, a disease whose pathogenesis has long been associated
with oxidative stress.
5. Conclusion
Thepresent study demonstrated the protective effect of TH in
ISO-induced MI in rats, as evidenced by its protective effect
on the release of cardiac markers in serum. In addition, our
BioMed Research International 7
study provided experimental evidence that TH improved the
antioxidant enzyme levels in heart tissue and lowered LPO
levels following exposure to high dose ISO. These biochem-
ical findings were further confirmed by histopathological
examination of both Tualang-honey-pretreated and ISO-
treated hearts. The present study demonstrated that the
cardioprotective effect of Tualang honey against ISO-induced
oxidative stress could be contributed by the presence of
endogenous antioxidant enzymes via inhibition of lipid
peroxidation.
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